Apar Kishor Ganti1, Valerie Shostrom2, Mohamed Alorabi3, Weining Ken Zhen4, Alissa S Marr5, Karin Trujillo6, K M Monirul Islam7, Rudy P Lackner6, Anne Kessinger5. 1. Department of Internal Medicine, VA Nebraska Western Iowa Health Care System, Omaha, NE; Department of Internal Medicine, Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE. Electronic address: aganti@unmc.edu. 2. Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE. 3. Department of Clinical Oncology, Ain Shams University Hospitals, Cairo, Egypt. 4. Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE. 5. Department of Internal Medicine, Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE. 6. Department of Surgery, Division of Cardiothoracic Surgery, University of Nebraska Medical Center, Omaha, NE; Department of Surgery, VA Nebraska Western Iowa Health Care System, Omaha, NE. 7. Department of Epidemiology, University of Nebraska Medical Center, Omaha, NE.
Abstract
BACKGROUND: The median age at diagnosis of lung cancer is 70 years. However, the evidence guiding the management of octogenarians and older patients with non-small-cell lung cancer (NSCLC), is based on data derived from younger patients and may not be appropriate. METHODS: Patients ≥ 80 years diagnosed with clinical stages I and II NSCLC, between 1988 and 2007, were identified from the SEER database. Patients were classified according to treatments received: no treatment, surgery only, radiation only, and surgery + radiation. Factors associated with survival were assessed using the Cox proportional hazards model. RESULTS: There were 1338 cases of early stage NSCLC in octogenarians. Surgery was the most common treatment modality. The median overall survival was 3.8 years for patients who had surgery, compared with 1.6 years, 1.6 years, and 0.9 years for those who received surgery + radiation, radiation alone, and no treatment, respectively (P < .0001). Factors significantly associated with worse overall survival following surgery included increasing age (hazard ratio [HR], 1.08; P = .0005), male gender (HR, 1.33; P = .01), stage II (HR, 2.21; P < .0001), and squamous histology (HR, 1.36; P = .01). CONCLUSION: Surgical resection is associated with long-term survival outcomes in a substantial proportion of octogenarian and older patients with early stage lung cancer and should not be withheld on the basis of age alone. Published by Elsevier Inc.
BACKGROUND: The median age at diagnosis of lung cancer is 70 years. However, the evidence guiding the management of octogenarians and older patients with non-small-cell lung cancer (NSCLC), is based on data derived from younger patients and may not be appropriate. METHODS:Patients ≥ 80 years diagnosed with clinical stages I and II NSCLC, between 1988 and 2007, were identified from the SEER database. Patients were classified according to treatments received: no treatment, surgery only, radiation only, and surgery + radiation. Factors associated with survival were assessed using the Cox proportional hazards model. RESULTS: There were 1338 cases of early stage NSCLC in octogenarians. Surgery was the most common treatment modality. The median overall survival was 3.8 years for patients who had surgery, compared with 1.6 years, 1.6 years, and 0.9 years for those who received surgery + radiation, radiation alone, and no treatment, respectively (P < .0001). Factors significantly associated with worse overall survival following surgery included increasing age (hazard ratio [HR], 1.08; P = .0005), male gender (HR, 1.33; P = .01), stage II (HR, 2.21; P < .0001), and squamous histology (HR, 1.36; P = .01). CONCLUSION: Surgical resection is associated with long-term survival outcomes in a substantial proportion of octogenarian and older patients with early stage lung cancer and should not be withheld on the basis of age alone. Published by Elsevier Inc.
Authors: Melisa L Wong; Timothy L McMurry; George J Stukenborg; Amanda B Francescatti; Carla Amato-Martz; Jessica R Schumacher; George J Chang; Caprice C Greenberg; David P Winchester; Daniel P McKellar; Louise C Walter; Benjamin D Kozower Journal: Lung Cancer Date: 2016-11-09 Impact factor: 5.705
Authors: Mitchell S von Itzstein; Arjun Gupta; Kemp H Kernstine; Kristin C Mara; Sahil Khanna; David E Gerber Journal: PLoS One Date: 2020-04-09 Impact factor: 3.240
Authors: Lei Liu; Jiaqi Zhang; Guige Wang; Ke Zhao; Chao Guo; Yeye Chen; Cheng Huang; Shanqing Li Journal: Thorac Cancer Date: 2021-11-03 Impact factor: 3.500